Browse Tag

A second study of the injectable anti-obesity medication

What works: Medication, a low-calorie diet, and intensive behavioral therapy

1 min read

The FINANCIAL -- A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing the reliability and robustness of this new drug. With obesity affecting more than 40% of American adults, the findings could have a major impact on weight management in primary care and other settings. The study is published in the Journal of the American Medical Association according to University of Pennsylvania.…

Read More »

What works: Medication, a low-calorie diet, and intensive behavioral therapy

1 min read

The FINANCIAL -- A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing the reliability and robustness of this new drug. With obesity affecting more than 40% of American adults, the findings could have a major impact on weight management in primary…